Landscapes / Companies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 3
4 in Phase 2
Drugs
10
in active trials
Trials
16 active
18 since 2021
Drugs10
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Chia Tai Tianqing Pharmaceutical Group |
Phase 3 | Dec 2026Phase 2 trial completes | ||
| Next date | Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Chronic Obstructive Pulmonary Disease, Asthma and 1 more | ||||
| Open drug page | |||||
— |
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical |
Phase 3 | May 2028Phase 3 trial completes | ||
| Next date | May 2028 · Phase 3 trial completes | ||||
| Also tested for | Metastatic Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 3 | Oct 2028Phase 3 trial completes | |||
| Next date | Oct 2028 · Phase 3 trial completes | ||||
| Also tested for | Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 3 | Oct 2028Phase 3 trial completes | |||
| Next date | Oct 2028 · Phase 3 trial completes | ||||
| Also tested for | Diffuse Large B Cell Lymphoma, Diffuse Large Cell B-lymphoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Seasonal Allergic Rhinitis | ||||
| Open drug page | |||||
— |
Phase 2 | 15 Aug 2027Phase 2 trial completes | |||
| Next date | 15 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Metabolic Dysfunction-Associated Steatoic Liver Disease | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Aug 2027Phase 1/2 trial completes | |||
| Next date | 31 Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Cancer, RAS/BRAF Wild Type Colorectal Cancer and 3 more | ||||
| Open drug page | |||||
— |
Chia Tai Tianqing Pharmaceutical Group |
Phase 1/2 | Feb 2029Phase 1/2 trial completes | ||
| Next date | Feb 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Systemic Light Chain Amyloidosis | ||||
| Open drug page | |||||
— |
Phase 1 | Aug 2027Phase 1 trial completes | |||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2028Phase 1 trial completes | |||
| Next date | Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Obesity / Overweight | ||||
| Open drug page | |||||
No drugs match “”.
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021